Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2006 4
2007 2
2008 3
2009 2
2010 1
2011 3
2012 9
2013 9
2014 2
2015 6
2016 6
2017 7
2018 8
2019 3
2020 13
2021 21
2022 31
2023 19
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAFV600E-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study.
Tsai HL, Huang CW, Chen YC, Su WC, Chang TK, Chen PJ, Li CC, Chang YT, Wang JY. Tsai HL, et al. Among authors: chen yc. Medicina (Kaunas). 2023 Dec 1;59(12):2108. doi: 10.3390/medicina59122108. Medicina (Kaunas). 2023. PMID: 38138211 Free PMC article.
The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study.
Tsai HL, Yeh YS, Chen PJ, Chang YT, Chen YC, Su WC, Chang TK, Huang CW, Wang JY. Tsai HL, et al. Among authors: chen yc. Integr Cancer Ther. 2023 Jan-Dec;22:15347354231187153. doi: 10.1177/15347354231187153. Integr Cancer Ther. 2023. PMID: 37822243 Free PMC article. Clinical Trial.
133 results